Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Implementing Shared Decision-Making for Multiple Sclerosis: The MS-SUPPORT Tool.
Col NF, Solomon AJ, Alvarez E, Pbert L, Ionete C, BerriosMorales I, Chester J, Kutz C, Iwuchukwu C, Livingston T, Springmann V, Col HV, Ngo LH. Col NF, et al. Among authors: livingston t. Mult Scler Relat Disord. 2023 Dec;80:105092. doi: 10.1016/j.msard.2023.105092. Epub 2023 Oct 21. Mult Scler Relat Disord. 2023. PMID: 37931489 Free article. Clinical Trial.
Comparative effectiveness of dimethyl fumarate versus fingolimod and teriflunomide among MS patients switching from first-generation platform therapies in the US.
Ontaneda D, Nicholas J, Carraro M, Zhou J, Hou Q, Babb J, Riester K, Mendoza JP, Livingston T, Jhaveri M. Ontaneda D, et al. Among authors: livingston t. Mult Scler Relat Disord. 2019 Jan;27:101-111. doi: 10.1016/j.msard.2018.09.038. Epub 2018 Oct 10. Mult Scler Relat Disord. 2019. PMID: 30368221 Free article.
A Novel Tool to Improve Shared Decision Making and Adherence in Multiple Sclerosis: Development and Preliminary Testing.
Col N, Alvarez E, Springmann V, Ionete C, Berrios Morales I, Solomon A, Kutz C, Griffin C, Tierman B, Livingston T, Patel M, van Leeuwen D, Ngo L, Pbert L. Col N, et al. Among authors: livingston t. MDM Policy Pract. 2019 Oct 16;4(2):2381468319879134. doi: 10.1177/2381468319879134. eCollection 2019 Jul-Dec. MDM Policy Pract. 2019. PMID: 31667351 Free PMC article.
Treatment satisfaction significantly improves in patients with multiple sclerosis switching from interferon beta therapy to peginterferon beta-1a every 2 weeks.
Hendin B, Naismith RT, Wray SE, Huang D, Dong Q, Livingston T, Jones DL, Watson C, Jhaveri M. Hendin B, et al. Among authors: livingston t. Patient Prefer Adherence. 2018 Jul 20;12:1289-1297. doi: 10.2147/PPA.S157317. eCollection 2018. Patient Prefer Adherence. 2018. PMID: 30050291 Free PMC article.
53 results